I don't think the agreement provides any opportunities. I think it provides obstacles. I do agree that there are many opportunities to lower Canadian drug costs, which are about the third highest in the world.
We have a very generous system of intellectual property protection for brand-name drugs already. For example, if you want to point to one distinction between Canada and Europe, Europe does not have a patent-linkage system and I actually find it a little galling that the European Union has used the CETA to force us to change our patent-linkage system when it is not permitted within Europe itself. I see that there are European models that Canada could emulate to control drug costs, but I don't think the CETA would further that; I think it would impair it.